Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07521124) titled 'ABC Maintenance Therapy for AML' on April 2.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Condition: Acute Myeloid Leukemia (AML) in Remission

Intervention: Drug: Cohort 1 (MRD-Negative Patients): 61 subjects

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: June 1, 2026

Target Sample Size: 104

Countries of Recruitment: China

To know more, visit https://clini...